WHO Global Report. Global Report on Diabetes. Isbn 2016; 978: 11.

Tim Riskesdas 2018. Laporan Nasional RISKESDAS 2018. Lembaga Penerbit LITBANGKES, 2018.

Al-Sharafi BA, Qais AA, Salem K, et al. Family history, consanguinity and other risk factors affecting the prevalence of prediabetes and undiagnosed diabetes mellitus in overweight and obese Yemeni adults. Diab Metab Syndr Obes Targets Ther. 2021;14:4853.

Muktabhant B, Sanchaisuriya P, Trakulwong M, et al. A first-degree relative with diabetes mellitus is an important risk factor for rural Thai villagers to develop type 2 diabetes mellitus. Asia-Pacific J Public Health. 2015;27:385–93.

Mittal M, Gupta HD. The study of prevalence of metabolic syndrome in the first-degree relatives of type 2 diabetes mellitus patients. Int J Res Med Sci. 2018;6:3042–6.

Purnamasari D, Soegondo S, Oemardi M, et al. Insulin resistance profile among siblings of type 2 diabetes mellitus (preliminary study). Acta Med Indones. 2010; 42(4):204–8.

Aman AM, Rasyid H, Bakri S, et al. The association between parents' history of type 2 diabetes with metabolic syndrome components and insulin resistance in non-diabetic young adult males. Acta Med Indones 2019;50:309.

Cleeman JI. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc. 2001;285:2486–97.

International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. 2006;28:1–2.

Siewert S, Filipuzzi S, Codazzi L, et al. Impact of metabolic syndrome risk factors in first-degree relatives of type 2 diabetic patients. Rev Diabet Stud 2007;4:177–184.

Purnamasari D, Aulia R, Abdaly MS, et al. Hypercholesterolemia as the first manifestation of metabolic abnormalities in a normoglycemic young adult male with a family history of type 2 diabetes mellitus. Diabetes Metab Syndr Clin Res Rev. 2019; 13:969–74.

Sonuga OO, Abbiyesuku FM, Adedapo KS, et al. Insulin resistance index and proatherogenic lipid indices in the offspring of people with diabetes. Int J Diabetes Metab. 2019;25:11–8.

Fan J, Liu Y, Yin S, et al. Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation. Nutr Metab (Lond); 16. Epub ahead of print 21 January 2019. DOI: 10.1186/S12986-019-0334-Y.

Sachdeva A, Cannon CP, Deedwania PC, et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J; 157. Epub ahead of print 2009. DOI: 10.1016/J.AHJ.2008.08.010.

Hoogeveen RC, Gaubatz JW, Sun W, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014;34:1069–77.

Tsai MY, Steffen BT, Guan W, et al. New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34:196–201.

Musunuru K, Orho-Melander M, Caulfield MP, et al. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol. 2009;29:1975–80.

Hoogeveen RC, Gaubatz JW, Dodge RC, et al. Small dense LDL cholesterol concentrations predict risk for coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arter Thromb Vasc Biol 2014;34:1069–1077.

Nishikura T, Koba S, Yokota Y, et al. Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease. J Atheroscler Thromb. 2014; 21:755–67.

Adiels M, Olofsson SO, Taskinen MR, et al. Overproduction of very low-density lipoproteins is the hallmark of dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:1225–36.

Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002; 43:1363–79.

Krayenbuehl PA, Wiesli P, Schmid C, et al. Insulin sensitivity in type 2 diabetes is closely associated with LDL particle size. Swiss Med Wkly. 2008;138:275–80.

Gerber PA, Thalhammer C, Schmied C, et al. Small, dense LDL particles predict changes in intima media thickness and insulin resistance in men with type 2 diabetes and prediabetes - A prospective cohort study. PLoS One. 2013;8:1–8.